Jyotsna Chawla

Dr. Jyotsna Chawla


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2024 in Cureus
Verified
Journal Article
Open access
PDF file
DPDhanvi Patel
Dhanvi Patel
JCJyotsna Chawla
Jyotsna Chawla
CBCyril Blavo
Cyril Blavo
The FDA's approval of Pfizer’s new respiratory syncytial virus (RSV) prefusion (preF) vaccine, Abrysvo, marks a critical milestone in infant health and well-being by preventing lower respiratory tract infections in the most vulnerable. The vaccine has been approved for administration to pregnant women at 32 to 36 weeks of gestation and elderly people over 60. This review explores the Abrysvo vaccine, detailing its mechanism, efficacy, safety, and adverse events. It aims to inform healthcare providers about this vital method for safeguarding infant respiratory health through maternal immunization.

12 September 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ERErica Rankin
Erica Rankin
AFAshley Forrest
Ashley Forrest
LMLahana Maharjan
Lahana Maharjan
GWGriffin Wei
Griffin Wei
CBCyril Blavo
Cyril Blavo
JCJyotsna Chawla
Jyotsna Chawla
Syphilis has experienced a marked resurgence in the United States since 2018, with incidence rates reaching levels not observed since the pre-antibiotic era. Despite growing awareness among healthcare professionals and public health authorities, a comprehensive epidemiological analysis of the populations most affected during this period remains limited. This study examines the rise in syphilis cases from 2018 to 2022 using surveillance data from the Centers for Disease Control and Prevention (CDC). We evaluate trends across key demographic variables including race, sexual behavior, geographic distribution, substance use, and sex of sexual partner. Additionally, we assess the role of socioeconomic determinants that may impede access to prevention, diagnosis, and treatment. By identifying disproportionately affected populations, this research aims to inform targeted public health interventions and guide evidence-based policy responses to mitigate the ongoing syphilis epidemic.

7 August 2024
Verified
Book Chapter
Open access
PDF file
JCJyotsna Chawla
Jyotsna Chawla
JBJoshua Bernard
Joshua Bernard
CBCyril Blavo
Cyril Blavo
Intestinal parasitic infections afflict over 3.5 billion individuals globally, leading to an estimated 200,000 deaths annually. Acknowledging variations in susceptibility and outcomes across diverse demographic groups is essential for effective intervention. This chapter provides an in-depth examination of medically significant intestinal parasites, including three protozoa, two nematodes, two cestodes, and one trematode, selected specifically for their primary pathogenesis within the intestines. We offer comprehensive insights into their morphology, pathogenesis mechanisms, and current and emerging diagnostic and therapeutic modalities. By fostering a deeper understanding of intestinal parasitic diseases, this work aims to contribute to the formulation of targeted intervention strategies, ultimately reducing morbidity and mortality associated with these widespread infections.

21 January 2026 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
RARia Ahuja
Ria Ahuja
ASAyleen Shaban
Ayleen Shaban
JCJyotsna Chawla
Jyotsna Chawla
Mayur Shanubhai ParmarMayur Shanubhai Parmar
Mayur Shanubhai Parmar

25 February 2026 in Cureus
Verified
Journal Article
Open access
PDF file
MGMatthew Green
Matthew Green
JCJyotsna Chawla
Jyotsna Chawla
CBCyril Blavo
Cyril Blavo
Neonatal sepsis remains a major cause of preventable newborn deaths worldwide despite advances in maternal screening, antibiotic use, and neonatal care. Persistent diagnostic delays, rising antimicrobial resistance (AMR), and unequal access to resources highlight the urgent need for new approaches. This review summarizes the primary pathogens responsible for early- and late-onset neonatal sepsis, along with their transmission routes, virulence factors, and clinical presentations. We examine promising innovations in rapid molecular diagnostics, next-generation sequencing, artificial intelligence (AI), maternal vaccination, and immunotherapies that have the potential to transform prevention and treatment strategies. By consolidating current evidence and addressing gaps in global care, this review calls for standardized protocols and equitable implementation of these advancements to reduce the global burden of neonatal sepsis.

16 September 2026 in Cureus
Verified
Journal Article
Open access
PDF file
ABArchana Banda
Archana Banda
KPKim Pedrigal
Kim Pedrigal
SJSavannah Jayne
Savannah Jayne
JCJyotsna Chawla
Jyotsna Chawla
The co-occurrence of tuberculosis (TB) and type 2 diabetes mellitus (T2DM) represents a growing global syndemic that disproportionately affects populations with limited access to healthcare and preventive resources. T2DM is an established independent risk factor for TB, while social determinants of health (SDoH) further contribute to disease susceptibility, delayed diagnosis, and poor clinical outcomes. This narrative literature review examines the impact of SDoH and modifiable lifestyle factors on the TB-T2DM syndemic and highlights opportunities for intervention. A literature review was conducted using PubMed and Google Scholar with keywords including “Type 2 Diabetes,” “Tuberculosis,” “Social Determinants of Health,” “health literacy,” “access to healthcare,” “smoking,” and “diet.” Existing literature demonstrates that health literacy, socioeconomic status, nutrition, and healthcare accessibility are major contributors to the dual disease burden. Smoking has been associated with impaired beta-cell function, worsened glycemic control, and increased susceptibility to TB infection and recurrence. In contrast, Mediterranean dietary patterns, structured exercise, and lifestyle modification have been shown to improve glycemic control and reduce systemic inflammation. Populations from lower socioeconomic backgrounds remain particularly vulnerable because of compounding barriers, including malnutrition, overcrowding, and limited healthcare access. Addressing behavioral risk factors and SDoH through early detection, patient education, and public health interventions is essential to mitigating the TB-T2DM syndemic. An interdisciplinary approach integrating clinical care, preventive medicine, and global health policy is critical to improving long-term outcomes in affected populations.